Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06271694 · ClinicalTrials.gov registry record · NA

Activity and Participation in Vestibular Disorders

A NA study of Vestibular Disorder, sponsored by University of Pittsburgh.

Recruiting
Registry status
NA
Development phase
67
Enrollment target
1
Study location

NCT06271694: Recruiting NA study of Vestibular Disorder, sponsored by University of Pittsburgh.

NCT06271694 is a NA study of Vestibular Disorder that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 67 participants, roughly in line with the 70-participant average among 6 other Vestibular Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06271694, a NA study of Vestibular Disorder, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
NA
Development phase
67 participants
Enrollment target
1
Study location

Study Summary

This study will examine whether impairments and personal factors are associated with activity and participation in people with vestibulopathy. Data collection will occur prior to starting vestibular rehabilitation and after completing vestibular rehabilitation.

Primary Outcome

Activity and Participation (raw 16-80; scale 0-100 min-max scores); higher is better

Conditions Studied

Interventions

  • OTHER Vestibular Rehabilitation

Study Locations (1)

Pennsylvania

  • UPMC-Rehab Institute - Pittsburgh

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2024-01-12
Est. Completion 2026-05-01
Phase NA
University of Pittsburgh

1,238 total trials

What NCT06271694 shows while recruiting

NCT06271694 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, roughly in line with the 70-participant average among 6 other Vestibular Disorder trials with a reported enrollment target.

The record links to 1 condition, with Vestibular Disorder appearing as the primary indexed condition, and to 1 intervention - of which Vestibular Rehabilitation is the first listed.

NCT06271694 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06271694 about?

NCT06271694 is a clinical study titled "Activity and Participation in Vestibular Disorders". This study will examine whether impairments and personal factors are associated with activity and participation in people with vestibulopathy. Data collection will occur prior to starting vestibular rehabilitation and after completing vestibular rehabilitation.

What is the current status of trial NCT06271694?

This trial is currently recruiting. It is a NA study. The enrollment target is 67 participants. The study started on 2024-01-12. Estimated completion is 2026-05-01.

What conditions does trial NCT06271694 study?

This clinical trial studies the following conditions: Vestibular Disorder.

What interventions are being tested in trial NCT06271694?

The interventions under investigation include: Vestibular Rehabilitation (OTHER).

Who is sponsoring clinical trial NCT06271694?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06271694 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Vestibular Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03213002 · 67 participants · Phase 1

    Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

  • NCT04115163 · 67 participants · Phase 2

    Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

  • NCT04315324 · 67 participants · Phase 1

    Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

  • NCT04532424 · 67 participants · NA

    Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06271694, the US trial registry maintained by the National Library of Medicine. NCT06271694 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.